Victory Capital Management Inc Cabaletta Bio, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 629,087 shares of CABA stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
629,087
Previous 634,217 0.81%
Holding current value
$2.49 Million
Previous $4.74 Million 37.4%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$3.94 - $8.24 $20,212 - $42,271
-5,130 Reduced 0.81%
629,087 $2.97 Million
Q2 2024

Aug 05, 2024
BUY
$7.22 - $18.82 $1.9 Million - $4.94 Million
262,594 Added 70.66%
634,217 $4.74 Million
Q1 2024

May 03, 2024
SELL
$16.79 - $25.38 $542,384 - $819,875
-32,304 Reduced 8.0%
371,623 $6.34 Million
Q4 2023

Feb 05, 2024
BUY
$12.21 - $23.36 $4.12 Million - $7.88 Million
337,277 Added 506.04%
403,927 $9.17 Million
Q3 2023

Nov 06, 2023
BUY
$11.84 - $18.65 $82,643 - $130,176
6,980 Added 11.7%
66,650 $1.01 Million
Q2 2023

Jul 27, 2023
BUY
$7.65 - $13.95 $456,475 - $832,396
59,670 New
59,670 $770,000
Q3 2022

Nov 02, 2022
SELL
$0.63 - $2.05 $72 - $235
-115 Reduced 0.27%
42,586 $28,000
Q2 2022

Aug 01, 2022
BUY
$0.99 - $2.11 $41 - $88
42 Added 0.1%
42,701 $45,000
Q1 2022

May 04, 2022
SELL
$1.68 - $3.92 $372,229 - $868,534
-221,565 Reduced 83.85%
42,659 $59,000
Q4 2021

Feb 07, 2022
BUY
$3.36 - $14.64 $149,311 - $650,572
44,438 Added 20.22%
264,224 $1 Million
Q3 2021

Nov 02, 2021
BUY
$7.0 - $12.5 $1.2 Million - $2.14 Million
171,529 Added 355.45%
219,786 $2.67 Million
Q2 2021

Aug 03, 2021
SELL
$7.2 - $11.73 $15,645 - $25,489
-2,173 Reduced 4.31%
48,257 $415,000
Q1 2021

May 04, 2021
SELL
$10.39 - $14.53 $477 - $668
-46 Reduced 0.09%
50,430 $560,000
Q4 2020

Feb 01, 2021
SELL
$9.81 - $15.8 $8,201 - $13,208
-836 Reduced 1.63%
50,476 $630,000
Q3 2020

Nov 09, 2020
SELL
$9.71 - $14.41 $196,151 - $291,096
-20,201 Reduced 28.25%
51,312 $556,000
Q2 2020

Aug 07, 2020
SELL
$6.39 - $11.28 $4,683 - $8,268
-733 Reduced 1.01%
71,513 $797,000
Q1 2020

May 04, 2020
SELL
$6.0 - $18.67 $16,524 - $51,417
-2,754 Reduced 3.67%
72,246 $527,000
Q4 2019

Feb 06, 2020
BUY
$7.88 - $17.71 $21,480 - $48,277
2,726 Added 3.77%
75,000 $1.05 Million
Q4 2019

Feb 04, 2020
BUY
$7.88 - $17.71 $569,519 - $1.28 Million
72,274 New
72,274 $1.19 Million

Others Institutions Holding CABA

# of Institutions
126
Shares Held
47.9M
Call Options Held
202K
Put Options Held
110K
View Full List

About Cabaletta Bio, Inc.

CABA Quotes by TradingView
  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $115M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email